Karyopharm Therapeutics Inc Annual Shareholders Meeting Transcript
Ladies and gentlemen. Welcome to the Karyopharm Therapeutics Inc. meeting. Your speaker for today, Michael Kauffman, will now begin.
Good afternoon. I am Michael Kauffman, Chief Executive Officer and the Director of Karyopharm Therapeutics. I'd like to welcome you all to Karyopharm's 2020 Annual Meeting of Stockholders. We have chosen to hold our annual meeting this year as a virtual meeting in order to better support the health and well-being of our stockholders, employees and directors in light of the COVID-19 outbreak, and we welcome you to this live webcast. We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting. It is now 2:00 p.m. Eastern time on this 21st day of May 2020, and I call this meeting to order.
I will be serving as Chairman of today's meeting, and I've asked Chris Primiano, our Executive Vice President, Chief Business Officer, General Counsel and Secretary, to act as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |